CLEVIPREX clevidipine 0.5 mg/mL injectable emulsion (25mg/50mL), 10mL vials (USA)
Section 19A approved medicine
CLEVIPREX clevidipine 0.5 mg/mL injectable emulsion (25mg/50mL), 10mL vials (USA)
Section 19A approval holder
Chiesi Australia Pty Ltd ABN 72 145 180 865
Phone
03 9077 4486
Approved until
Status
Current
Medicines in short supply/unavailable
CLEVIPREX clevidipine, 25 mg in 50 mL injectable emulsion, Single Use Vials - ARTG 203313
Indication(s)
Cleviprex is indicated for the short-term treatment of hypertension when oral therapy is not feasible or desirable.
Images
